Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.
about
Profile of nimotuzumab in the treatment of high-grade gliomaExpression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines.Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repairWTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients.
P2860
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nimotuzumab as a radiosensitiz ...... challenges and opportunities.
@en
type
label
Nimotuzumab as a radiosensitiz ...... challenges and opportunities.
@en
prefLabel
Nimotuzumab as a radiosensitiz ...... challenges and opportunities.
@en
P2860
P356
P1476
Nimotuzumab as a radiosensitiz ...... challenges and opportunities.
@en
P2093
Arlhee Diaz-Miqueli
Giselle Saurez Martinez
P2860
P304
P356
10.2147/OTT.S33532
P407
P577
2013-07-24T00:00:00Z